In: FEMS Microbiology Letters, 1996, vol. 136, no. 1, p. 31-37
|
In: Journal of Antimicrobial Chemotherapy, 2015, vol. 70, no. 1, p. 75-80
|
In: Clinical Microbiology and Infection, 2017, p. -
To evaluate whether acquired resistance to cationic antimicrobial peptides (CAMP) group molecules, being normal components of the human immune system, may select co-resistance to antibiotic peptides such as polymyxins, considering they share the same mechanism of action. We aimed to evaluate strains producing the recently identified plasmid-encoded polymyxin resistance determinant MCR-1,...
|
In: Journal of Antimicrobial Chemotherapy, 2015, vol. 70, no. 1, p. 75-80
Objectives Alterations in the PhoPQ two-component regulatory system may be associated with colistin resistance in Klebsiella pneumoniae. MgrB is a small transmembrane protein produced upon activation of the PhoPQ signalling system, and acts as a negative regulator on this system. We investigated the role of the MgrB protein as a source of colistin resistance in a series of K. pneumoniae.Methods...
|
In: New Microbes and New Infections, 2014, vol. 2, no. 2, p. 50–51
We report here the first identification of the worldwide spread of Klebsiella pneumoniae carbapenemase-2-producing and carbapenem-resistant K. pneumoniae clone ST258 in Turkey, a country where the distantly-related carbapenemase OXA-48 is known to be endemic. Worryingly, this isolate was also resistant to colistin, now considered to be the last-resort antibiotic for carbapenem-resistant isolates.
|